Application of Thermally Responsive Elastin-like Polypeptide Fused to a Lactoferrin-derived Peptide for Treatment of Pancreatic Cancer

A well characterized, peptide derivative of bovine lactoferrin, L12, has been shown to possess anticancer properties in multiple cell lines. However, adverse side effects in normal tissues and poor plasma kinetics that hinder the clinical effectiveness of current chemotherapeutics also deter the potential for effective delivery of this L12 peptide. To overcome these limitations, we have developed an Elastin-like polypeptide (ELP) carrier that has the potential to thermally target therapeutic peptides and chemotherapeutics to a tumor site. The coding sequence of ELP was modified with the L12 peptide at the C-terminus and a membrane transduction domain derived from the HIV-1 Tat protein at the N-terminus (Tat-ELP-L12). The thermally responsive Tat-ELP1-L12 is soluble in aqueous solutions at 37°C but aggregates near 41°C, which makes Tat-ELP1-L12 ideal for targeting to solid tumors on application of focused hyperthermia. We observed that under hyperthermia conditions at 42°C, Tat-ELP1-L12 mediated cytotoxicity in MIA PaCa-2 pancreatic adenocarcinoma cells was enhanced by nearly thirty-fold. We investigated the mechanisms of cell death and found evidence of mitochondrial membrane depolarization and caspase activation, which are characteristic of apoptosis, as well as, increased membrane permeability, as shown by LDH release. These results suggest that Tat-ELP1-L12 possesses cytotoxic properties to cancer cells in vitro and may have the potential to provide an effective vehicle to thermally target solid tumors.

[1]  D. Hoskin,et al.  Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. , 2007, Experimental cell research.

[2]  S. White,et al.  Structure, location, and lipid perturbations of melittin at the membrane interface. , 2001, Biophysical journal.

[3]  H. Maeda,et al.  Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. , 1992, Bioconjugate chemistry.

[4]  A. El-Aneed,et al.  An overview of current delivery systems in cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[5]  T. M. Parker,et al.  Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity , 1991 .

[6]  B. Sveinbjørnsson,et al.  The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo , 2006, International journal of cancer.

[7]  Z. Lu,et al.  HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  Ashutosh Chilkoti,et al.  Purification of recombinant proteins by fusion with thermally-responsive polypeptides , 1999, Nature Biotechnology.

[9]  M. Pincus,et al.  Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site , 2003, Oncogene.

[10]  J. Kopeček,et al.  Intracellular targeting of polymer-bound drugs for cancer chemotherapy. , 2005, Advanced drug delivery reviews.

[11]  P. Shewry,et al.  Elastomeric proteins: biological roles, structures and mechanisms. , 2000, Trends in biochemical sciences.

[12]  T. Allen.  Liposomal drug formulations. Rationale for development and what we can expect for the future. , 1998, Drugs.

[13]  J. Temsamani,et al.  Antisense oligonucleotides: a new therapeutic approach , 1997, Biotechnology and applied biochemistry.

[14]  J. Svendsen,et al.  The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells , 2004, Journal of peptide science : an official publication of the European Peptide Society.

[15]  G. Bidwell,et al.  Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy , 2005, Molecular Cancer Therapeutics.

[16]  Steven F. Dowdy,et al.  Cell Penetrating Peptides in Drug Delivery , 2004, Pharmaceutical Research.

[17]  M. Dewhirst,et al.  Drug targeting using thermally responsive polymers and local hyperthermia. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  V. Torchilin.  Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[19]  S. Kaye,et al.  Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. , 1989, Biochemical pharmacology.

[20]  M. Dewhirst,et al.  Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. , 2001, Cancer research.

[21]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[22]  G. Bidwell,et al.  Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Friedrich Paulsen,et al.  Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. , 2006, European urology.

[24]  T Watanabe,et al.  Effects of Hyperthermia, Radiotherapy and Thermoradiotherapy on Tumor Microvascular Permeability , 1990, Acta pathologica japonica.

[25]  R. Nicholson,et al.  Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. , 2005, Endocrine-related cancer.

[26]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[27]  W. Watanabe,et al.  A colorimetric LDH assay for the titration of infectivity and the evaluation of anti-viral activity against ortho- and paramyxoviruses. , 1995, The Tohoku journal of experimental medicine.

[28]  Y. Yoo,et al.  Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice. , 1998, Advances in experimental medicine and biology.

[29]  Y. Ikada,et al.  Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. , 1994, Journal of pharmaceutical sciences.

[30]  J. Temsamani,et al.  The use of cell-penetrating peptides for drug delivery. , 2004, Drug discovery today.

[31]  Yasuo Watanabe,et al.  A lactoferrin‐derived peptide with cationic residues concentrated in a region of its helical structure induces necrotic cell death in a leukemic cell line (HL‐60) , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[32]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[33]  David M. Conrad,et al.  Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines , 2005, Molecular Cancer Therapeutics.

[34]  R. Jain,et al.  Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. , 1985, International journal of microcirculation, clinical and experimental.

[35]  G. Bidwell,et al.  Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. , 2007, Biochemical pharmacology.

[36]  J. Svendsen,et al.  Enhanced antitumor activity and selectivity of lactoferrin-derived peptides. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[37]  D. Raucher,et al.  A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells* , 2007, Journal of drug targeting.

[38]  G. Bidwell,et al.  Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc. , 2006, Biochemical pharmacology.

[39]  M. Hashida,et al.  Disposition Characteristics of Macromolecules in Tumor-Bearing Mice , 1990, Pharmaceutical Research.

[40]  G. Kroemer,et al.  The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.

[41]  G. Konjević,et al.  A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay. , 1999, Cancer letters.

[42]  Y. Yoo,et al.  Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. , 1997, Biochemical and biophysical research communications.

[43]  A. Chilkoti,et al.  Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[45]  Ashutosh Chilkoti,et al.  Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. , 2002, Advanced drug delivery reviews.